Preprints.org
Artificial Intelligence in Alzheimer’s Disease: Evidence Maturity and Clinical Translation Across the Care Pathway
Preprint: systematic reviewBiomarkers
Abstract
Artificial intelligence (AI) is now a credible translational research platform across the Alzheimer’s disease (AD) pathway, but its clinical value is often difficult to judge from performance metrics alone.
The paper
Preprints.org, 30 Jul 2026, CC BY, Preprint, not peer-reviewed
